| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10008931 | Annals of Allergy, Asthma & Immunology | 2005 | 8 Pages |
Abstract
These findings confirm the safety of ciclesonide therapy, demonstrating that at doses up to 640 μg/d, the drug does not affect sensitive markers of adrenal function.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Brian J. MD, Michael A. MD, Craig F. MD, James W. MD, Harold B. MD, Dilip PhD, Sudeep PhD, James E. MD, Renate PhD, Donald D. MD,